The Bulls N' Bears ASX Runner of the Week is… Bison Resources, which more than tripled on debut after a heavily oversubscribed $5.5 million IPO to chase gold and silver in Nevada's world-class Carlin Trend. Genetic Signatures charged higher on a major Danish hospital supply contract for its gastrointestinal diagnostic assay, Narryer Metals more than doubled on a premium placement backed by veteran investor Tim Goyder, and Immutep rebounded strongly after securing FDA Orphan Drug Designation for its efti alfa drug for soft tissue sarcoma.
